Moran M, Guzman J, Henderson K, Liyanage R, Wu L, Chin E, Chapman N, Abela-Oversteegen L, Gouglas D, Kwong D, (2012)
G-FINDER 2012 - Neglected disease research and development: A five year review, Policy Cures.
Saving lives and creating impact: EU investment in poverty-related neglected diseases, Policy Cures; Deutsche Stiftung Weltbevoelkerung (DSW).
Saving lives and creating impact: Why investing in global health research works, Policy Cures; Global Health Technology Coalition (GHTC).
Staying the course? Malaria research and development in a time of economic uncertainty Policy Cures; PATH.
Moran M, Guzman J, Abela-Oversteegen L, Liyanage R, Omune B, Wu L, Chapman N, Gouglas D, (2011)
Neglected disease research and development: Is innovation under threat? Policy Cures.
Moran M, Guzman J, Henderson K, Abela-Oversteegen L, Wu L, Omune B, Gouglas D, Chapman N, Zmudzki F (2010)
Neglected disease research and development: Is the global financial crisis changing R&D? Policy Cures.
Moran M, Strub-Wourgaft N, Guzman J, Boulet P, Wu L, et al. (2011) Registering New Drugs for Low-Income Countries: The African Challenge. PLoS Med 8(2): e1000411. doi:10.1371/journal.pmed.1000411
Hanson K, Palafox B, Anderson S, Guzman J, Moran M, Shretta R, Wuliji T (2010). Pharmaceuticals. In: Merson M, Black R, Mills A Global Health: Diseases, Programs, Systems and Policies, 3rd ed. London: Jones and Bartlett. In Press.
Moran M, Guzman J, Ropars AL, Illmer A (2010). The role of Product Development Partnerships in research and development for neglected diseases. International Health. June 2010 (Vol. 2, Issue 2, Pages 114-122, DOI: 10.1016/j.inhe.2010.04.002)
Moran M (2010). Funding for research and development and the financial crisis. Lancet Infectious Diseases (10): 214-215.
Berger, M; Murugi, J; Buch, E; IJsselmuiden C; Moran, M; Guzman, J; Devlin, M; Kubata, B.
Strengthening pharmaceutical innovation in Africa. Council on Health Research for Development (COHRED); New Partnership for Africa’s Development (NEPAD).
Moran M, Guzman J, McDonald A, Wu L, Omune B (2010)
Registering New Drugs: The African Context: New tools for new times. Health Policy Division, The George Institute for International Health
Moran M, Guzman J, Henderson K, Ropars AL, McDonald A, McSherry L, Wu L, Omune B, Illmer A, Sturm T, Zmudzki F (2009)
Neglected disease research and development: New times, new trends. The George Institute for International Health.
Moran M, Guzman J, Henderson K, McDonald A, Omune B (2009). Giving innovation a push: public and philanthropic R&D funding. Global Forum Update on Research for Health 6. Global Forum for Health Research.
Moran M, Guzman J, Ropars AL, McDonald A, Sturm T, Jameson N, Wu L, Ryan S, Omune B (2009)
Neglected disease research and development: how much are we really spending? The George Institute for International Health.
Moran M, Guzman J, Ropars AL, McDonald A, Jameson N, et al. (2009) Neglected disease research and development: how much are we really spending? PLoS Med 6(2): e1000030
Moran M, Guzman J, Ropars A, Jorgensen M, McDonald A, Potter S and Haile-Selassie H (2008) Clinical trial site capacity for malaria product development. Health Partnerships Review: Focusing collaborative efforts on research and innovation for the health of the poor. Global Forum for Health Research.
Moran M, Ropars AL, Guzman J (2007). Partnership dynamics, issues and challenges. Global Forum Update on Research for Health Volume 4. Global Forum for Health Research.
Moran M, Guzman J, Ropars A, Jorgensen M, McDonald A, Potter S and Haile-Selassie H (2007) The malaria product pipeline: planning for the future. The George Institute for International Health.
Moran M, Ropars AL, Guzman J (2007). Partnership dynamics, issues and challenges. Global Forum Update on Research for Health Volume 4. Global Forum for Health Research.
Moran M, Guzman J, Ropars A, Jorgensen M, McDonald A, Potter S and Haile-Selassie H (2007)
The malaria product pipeline: planning for the future. The George Institute for International Health.
Moran M, Guzman J, Ropars A and Evans A (2007) Neglected Diseases, Doctors Can Make a Difference. British Medical Association.
Moran M and Guzman J (2006) Drug R&D for neglected diseases by public-private partnerships: are public funds appropriately distributed? Monitoring Financial Flows for Health Research 2005:Behind the Global Numbers. Global Forum for Health Research.
Moran M (2006) The New Landscape of Neglected Disease Drug Development. Annual Report 2005. Medicines for Malaria Venture.
Moran M, Ropars AL, Guzman J, Diaz J and Garrison C (2005)
The new landscape of neglected disease drug development. London School of Economics and The Wellcome Trust.
Moran M and Guzman J (2005) Neglected disease drug development: How big is the gap? Forum 9. Global Forum for Health Research.